GlassScriptPhysician profile
Mohammad F Mathbout
NPI 1912389826
$9,368.22
in general payments reported to CMS, 2019-2025
28 companies · $980 in 2025
The $980 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $710 · 2020: $461 · 2021: $687 · 2022: $1,647 · 2023: $4,193 · 2024: $691 · 2025: $980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,587 · Travel and Lodging: $2,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,587.09 |
| Travel and Lodging | $2,276.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $3,322.64 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $1,876.69 | 2019-2025 | Avvigo Guidance System, Crossboss, Ilab Ultrasound Imaging System |
| Medtronic, INC. | $952.49 | 2021-2025 | Ffrangio, Symplicity G3, Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $556.32 | 2019-2025 | Lifevest |
| W. L. Gore & Associates, INC. | $528.65 | 2023 | Gore Cardioform Septal Occluder |
| Abiomed | $405.37 | 2023-2025 | Impella |
| Penumbra, INC. | $254.87 | 2022-2025 | Indigo System |
| Medtronic Vascular, INC. | $203.68 | 2019-2020 | |
| Cardiovascular Systems INC. | $183.94 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $142.50 | 2019-2021 | |
| Abbott Laboratories | $138.44 | 2020-2021 | |
| Amgen INC. | $121.86 | 2022 | |
| Stryker Corporation | $120.16 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Novo Nordisk INC | $114.54 | 2019 | |
| Osprey Medical INC | $106.79 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 200 LLC | $99.43 | 2019 | |
| Philips North America LLC | $36.58 | 2020 | |
| Terumo Medical Corporation | $33.64 | 2020 | |
| Shockwave Medical, INC | $27.06 | 2025 | |
| Cardiva Medical, INC. | $24.02 | 2022 | |
| Teleflex LLC | $20.49 | 2025 | Manta |
| Livanova USA, INC. | $19.74 | 2023 | Lifesparc |
| Angiodynamics, INC. | $14.32 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.22 | 2021 | |
| Pfizer INC. | $13.88 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.45 | 2019 | |
| Verge Medical, INC. | $13.32 | 2020 | |
| Zoll Circulation INC | $9.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Mathbout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.